Burjeel Holdings, one of the leading super-specialty healthcare providers in the MENA region, has announced strong financial results for the financial year ended December 31, 2025, reporting a significant increase in revenue and profitability.
According to the group’s unaudited preliminary financial results, Burjeel Holdings’ revenue grew by 9.8% year-on-year to AED 5,501 million (approximately INR 135.7 billion). Patient visits increased by 8.4% during the year, crossing the 7 million mark, reflecting sustained demand across its healthcare facilities.
EBITDA rose by 19.9% to AED 1,089 million (INR 26.9 billion), with EBITDA margins improving to 19.8%, compared to 18.1% in 2024. Net profit recorded a sharp growth of 39.5%, reaching AED 503 million (INR 12.4 billion), while net profit margin improved to 9.1%. The fourth quarter of 2025 delivered particularly strong results, with net profit growth of 159.9%.
Inpatient and outpatient volumes grew by 11.7% and 8.3% respectively. Burjeel Holdings also carried out more than 89,700 surgeries across its key facilities, including Burjeel Medical City, Medeor Hospital Abu Dhabi, Burjeel Hospital Abu Dhabi, and Lifecare Hospital Musaffah.
Dr. Shamsheer Vayalil, Chairman and CEO of Burjeel Holdings, attributed the strong performance to targeted interventions aligned with regional market needs, strategic expansion beyond core markets, and continued investment in integrated care networks and complex care services. He reaffirmed the group’s commitment to delivering high-quality healthcare services and creating sustainable long-term value for shareholders.
